These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16467371)

  • 1. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits.
    Mühlhäuser U; Zolk O; Rau T; Münzel F; Wieland T; Eschenhagen T
    FASEB J; 2006 Apr; 20(6):785-7. PubMed ID: 16467371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
    Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
    Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras.
    Pomerantz KB; Lander HM; Summers B; Robishaw JD; Balcueva E; Hajjar DP
    Biochemistry; 1997 Aug; 36(31):9523-31. PubMed ID: 9235998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
    Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
    Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.
    Rau T; Nose M; Remmers U; Weil J; Weissmüller A; Davia K; Harding S; Peppel K; Koch WJ; Eschenhagen T
    FASEB J; 2003 Mar; 17(3):523-5. PubMed ID: 12631586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation.
    Tanaka K; Honda M; Takabatake T
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):360-4. PubMed ID: 15191412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
    Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
    Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling components involved in the coupling of alpha 1-adrenoceptors to phospholipase D in neonatal rat cardiac myocytes.
    Gosau N; Fahimi-Vahid M; Michalek C; Schmidt M; Wieland T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):468-76. PubMed ID: 12070761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
    Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
    Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
    Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
    Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
    Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
    Ostrom RS; Violin JD; Coleman S; Insel PA
    Mol Pharmacol; 2000 May; 57(5):1075-9. PubMed ID: 10779394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells.
    Rodrigues AC; Curi R; Hirata MH; Hirata RD
    Eur J Pharm Sci; 2009 Jun; 37(3-4):486-91. PubMed ID: 19394420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling.
    Szabo-Fresnais N; Lefebvre F; Germain A; Fischmeister R; Pomérance M
    Cell Signal; 2010 Jul; 22(7):1143-52. PubMed ID: 20227492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
    Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
    Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats.
    Yao L; Chen GP; Lu X; Zheng LR; Mou Y; Hu SJ
    Basic Res Cardiol; 2009 May; 104(3):258-68. PubMed ID: 18836677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.